Jesús F. San Miguel

10 ta ish

Navarra University Clinic

1. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

   Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25

   Maqola20217 iqtibos

   ABIABI:AkademIndex/2026.other.296878

2. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

   S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo +31

   Maqola20143 iqtibos

   ABIABI:AkademIndex/2026.other.466311

3. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

   Michèle Cavo, Evangelos Terpos, Cristina Nanni +25

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.466312

4. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

   Mattia D’Agostino, David A. Cairns, Juan José Lahuerta +28

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.466336

5. Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

   Joaquín Martínez‐López, Juan José Lahuerta, François Pépin +21

   Maqola20142 iqtibos

   ABIABI:AkademIndex/2026.other.480111

6. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

   Elı́as Campo, Elaine S. Jaffe, James R. Cook +70

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.480200

7. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

   Juan‐José Garcés, María‐Teresa Cedena, Noemí Puig +25

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.480203

8. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma

   Tomáš Jelı́nek, Renata Bezděková, David Žihala +27

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.480213

9. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

   Hervé Avet‐Loiseau, Faith E. Davies, Mehmet Samur +43

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.480252

10. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

    Juan Flores‐Montero, Luzalba Sanoja-Flores, Bruno Paiva +30

    Maqola20172 iqtibos

    ABIABI:AkademIndex/2026.other.881528